You are here
Fabricio Oliveira, MD, BBA, MSc, PhD
Federal University of São Paulo - UNIFESP
Areas of Interest:
Neurological Rehabilitation, biomarkers of cognitive decline, pharmacogenetics, aphasia, behavior, language, learning and memory, cerebrospinal fluid biomarkers, blood biomarkers, neurodegenerative diseases, Alzheimer's disease, Lewy body dementia
Biography & Research:
Fabricio Ferreira de Oliveira MD BBA MSc PhD is the Executive Medical Director of the Elysian Clinic in São Paulo, a Medical Doctor and a Bachelor in Business Administration, Master of Sciences in Medical Sciences (Neurology), Philosopher Doctor in Medicine (Neurology), Internist and Mentor at the A. C. Camargo Cancer Center, Medical Researcher of the Federal University of São Paulo - UNIFESP, member of the American Academy of Neurology International Subcommittee, of the European Science Foundation Community of Experts, of the Awards Committee of the International Parkinson and Movement Disorder Society (MDS, 2021-2023), and of the Executive Committee of the ISTAART Biofluid Based Biomarkers Professional Interest Area (Alzheimer's Association, 2018-2023), and a healthcare advisor for several international consulting firms. He has been awarded the following prizes in the field of Neurology: 2019 Vascular Cognitive Disorders Professional Interest Area 3MT Competition (Alzheimer's Association, Los Angeles/USA), 2018 Travel Grant Award (International Parkinson and Movement Disorder Society, Hong Kong/CHINA), 2018 Travel Fellowship (Alzheimer's Association, Chicago/USA), 2017 Global Brain Health Institute Scholarship (GBHI - Global Brain Health Institute, Barcelona/SPAIN), 2016-2017 Who's Who in Science and Engineering (Marquis Who's Who, 12th edition, USA), 2016 Travel Fellowship (Alzheimer's Association, Toronto/CANADA), 2014 Travel Fellowship (Alzheimer's Association, Copenhagen/DENMARK), 2014 Who's Who in the World (Marquis Who's Who, 31st edition, USA), 2011-2012 Who's Who in Medicine and HealthCare (Marquis Who's Who, 8th edition, USA), Fundo de Auxílio aos Docentes e Alunos 2011 (UNIFESP - Escola Paulista de Medicina, São Paulo/BRAZIL), 2009 International Scholarship Award (AAN - American Academy of Neurology, Seattle/USA), Prêmio Roberto Melaragno Filho 2009 (APM/AMB - Associação Paulista de Medicina/Associação Paulista de Neurologia, Guarujá/BRAZIL), Desafio NeuroCiências 2009 (UNICAMP - State University of Campinas, Campinas/BRAZIL), 2008 Scholarship for Young Physicians (WSO/WHO - World Stroke Organization/World Health Organization, Vienna/AUSTRIA) and 2005 Federation Bursary (WFN - World Federation of Neurology, Sydney/AUSTRALIA). He was previously a member of the ISTAART Advisory Council (Alzheimer's Association, 2018-2021), an affiliate professor (2016-2019) of the Department of Neurology and Neurosurgery of the Federal University of São Paulo - UNIFESP, a post-doctoral fellow (2015-2018) of The State of São Paulo Research Foundation - FAPESP, a senior physician (2002-2004) and the leader of the Brain Injured Patients' Rehabilitation Program (4th floor - 64 beds) at the SARAH Network of Rehabilitation Hospitals - SARAH Brasília. He is certified by CREMESP and the Brazilian Academy of Neurology as an expert in Internal Medicine (Medical Residency at the Federal University of Rio de Janeiro - UFRJ: 03/2000-02/2002) and Neurology (Medical Residency at the State University of Campinas - UNICAMP: 02/2005-01/2007). His medical graduation was from 1994 to 1999 at the State University of Rio de Janeiro, and his business administration graduation was from 2006 to 2009 at the Pontifical Catholic University of Campinas. He has worked with 360 collaborators in his scientific and professional activities. He has been a member of the editorial board and/or reviewer for 95 international medical journals, for the International Scholarship Award, the de Leon Prize in Neuroimaging and the Alzheimer Award, besides advising the Brazilian Ministry of Health, Brazilian State Research Foundations (FAPESP, FAPERGS, FAPT), the Consortium for the Harmonization of Neuropsychological Assessment for Neurocognitive Disorders and the Global Biomarker Standardization Consortium, the Times Higher Education World Reputation Rankings, the Elsevier Advisory Panel and the Kudos Preview Program, and reviewing abstracts for the Alzheimer's Association: Alzheimer's Association International Conference, PIA Day, Neuroscience Next, Alzheimer's Imaging Consortium and Technology and Dementia PreConference.